0.8 PLN
926.25 K PLN
22.48 M PLN
About GENOMED
Sector
Industry
CEO
Anna Boguszewska-Chachulska
Website
Headquarters
Warsaw
Founded
2007
ISIN
PLGNOMD00024
FIGI
BBG001P21SH4
Genomed SA engages in the provision of medical diagnostic services. It offers DNA analysis and congenital diseases diagnostics based on DNA sequencing for scientific centers, biotechnological companies, and medical institutions. The company was founded by Andrzej Henryk Palucha, Anna Boguszewska-Chachulska, Marek Zagulski, and Iwona Wach on September 5, 2007 and is headquartered in Warsaw, Poland.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of GEN is 26.2 PLN — it has increased by 4.80% in the past 24 hours. Watch GENOMED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NEWCONNECT exchange GENOMED stocks are traded under the ticker GEN.
GEN stock has risen by 3.15% compared to the previous week, the month change is a 0.77% rise, over the last year GENOMED has showed a −12.67% decrease.
GEN stock is 0.00% volatile and has beta coefficient of −0.29. Track GENOMED stock price on the chart and check out the list of the most volatile stocks — is GENOMED there?
Today GENOMED has the market capitalization of 34.62 M, it has increased by 3.15% over the last week.
Yes, you can track GENOMED financials in yearly and quarterly reports right on TradingView.
GEN net income for the last quarter is 354.75 K PLN, while the quarter before that showed −175.44 K PLN of net income which accounts for 302.21% change. Track more GENOMED financial stats to get the full picture.
GENOMED dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 28, 2024, the company has 45.00 employees. See our rating of the largest employees — is GENOMED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENOMED EBITDA is 2.27 M PLN, and current EBITDA margin is 9.16%. See more stats in GENOMED financial statements.
Like other stocks, GEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENOMED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENOMED technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENOMED stock shows the sell signal. See more of GENOMED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.